APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lung Tumor Ablation

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lung Tumor Ablation Market Analysis and Forecast 2026-2032

Report ID 17442613045 July 2026173 pages

Choose your research edition.

Industry ResearchLung Tumor Ablation Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Tumor Ablation Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lung Tumor Ablation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Tumor Ablation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Tumor Ablation Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global Lung Tumor Ablation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Lung Tumor Ablation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lung Tumor Ablation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lung Tumor Ablation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lung Tumor Ablation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Lung Tumor Ablation include Angiodynamics, Auris Health, Intuitive Surgica, Nanjing MICRO-TECH, Smith and Nephew, VISON Medical, Olympus, Boston Scientific and Broncus, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Lung Tumor Ablation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lung Tumor Ablation, also provides the revenue of main regions and countries. Of the upcoming market potential for Lung Tumor Ablation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lung Tumor Ablation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lung Tumor Ablation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lung Tumor Ablation revenue, projected growth trends, production technology, application and end-user industry.

Lung Tumor Ablation Segment by Company

Angiodynamics

Auris Health

Intuitive Surgica

Nanjing MICRO-TECH

Smith and Nephew

VISON Medical

Olympus

Boston Scientific

Broncus

LungCare

Medtronic

TIPC

Lung Tumor Ablation Segment by Type

Microwave Ablation (MWA)

Radiofrequency Ablation (RFA)

Cold Ablation

Others

Lung Tumor Ablation Segment by Application

Hospitals

Ambulatory Surgical Centers

Lung Tumor Ablation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Tumor Ablation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lung Tumor Ablation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lung Tumor Ablation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lung Tumor Ablation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lung Tumor Ablation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microwave Ablation (MWA) Major Player Table 3. Radiofrequency Ablation (RFA) Major Player Table 4. Cold Ablation Major Player Table 5. Others Major Player Table 6. Global Lung Tumor Ablation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Player Table 8. Ambulatory Surgical Centers Major Player Table 9. Lung Tumor Ablation Industry Trends Table 10. Lung Tumor Ablation Industry Drivers Table 11. Lung Tumor Ablation Industry Opportunities and Challenges Table 12. Lung Tumor Ablation Industry Restraints Table 13. Global Lung Tumor Ablation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Lung Tumor Ablation Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Lung Tumor Ablation Market Share by Region (2021-2026) Table 16. Global Lung Tumor Ablation Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Lung Tumor Ablation Market Share by Region (2027-2032) Table 18. Global Lung Tumor Ablation Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Lung Tumor Ablation Revenue Market Share by Players (2021-2026) Table 20. Global Lung Tumor Ablation Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Lung Tumor Ablation Key Players Headquarters & Area Served Table 22. Global Lung Tumor Ablation Players, Product Type & Application Table 23. Global Lung Tumor Ablation Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Lung Tumor Ablation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Lung Tumor Ablation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Lung Tumor Ablation Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Lung Tumor Ablation Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Lung Tumor Ablation Revenue Market Share by Type (2021-2026) Table 30. Global Lung Tumor Ablation Revenue Market Share by Type (2027-2032) Table 31. Global Lung Tumor Ablation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Lung Tumor Ablation Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Lung Tumor Ablation Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Lung Tumor Ablation Revenue Market Share by Application (2021-2026) Table 35. Global Lung Tumor Ablation Revenue Market Share by Application (2027-2032) Table 36. Angiodynamics Company Information Table 37. Angiodynamics Business Overview Table 38. Angiodynamics Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Angiodynamics Lung Tumor Ablation Product Portfolio Table 40. Angiodynamics Recent Development Table 41. Auris Health Company Information Table 42. Auris Health Business Overview Table 43. Auris Health Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Auris Health Lung Tumor Ablation Product Portfolio Table 45. Auris Health Recent Development Table 46. Intuitive Surgica Company Information Table 47. Intuitive Surgica Business Overview Table 48. Intuitive Surgica Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Intuitive Surgica Lung Tumor Ablation Product Portfolio Table 50. Intuitive Surgica Recent Development Table 51. Nanjing MICRO-TECH Company Information Table 52. Nanjing MICRO-TECH Business Overview Table 53. Nanjing MICRO-TECH Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Nanjing MICRO-TECH Lung Tumor Ablation Product Portfolio Table 55. Nanjing MICRO-TECH Recent Development Table 56. Smith and Nephew Company Information Table 57. Smith and Nephew Business Overview Table 58. Smith and Nephew Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Smith and Nephew Lung Tumor Ablation Product Portfolio Table 60. Smith and Nephew Recent Development Table 61. VISON Medical Company Information Table 62. VISON Medical Business Overview Table 63. VISON Medical Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. VISON Medical Lung Tumor Ablation Product Portfolio Table 65. VISON Medical Recent Development Table 66. Olympus Company Information Table 67. Olympus Business Overview Table 68. Olympus Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Olympus Lung Tumor Ablation Product Portfolio Table 70. Olympus Recent Development Table 71. Boston Scientific Company Information Table 72. Boston Scientific Business Overview Table 73. Boston Scientific Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Boston Scientific Lung Tumor Ablation Product Portfolio Table 75. Boston Scientific Recent Development Table 76. Broncus Company Information Table 77. Broncus Business Overview Table 78. Broncus Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Broncus Lung Tumor Ablation Product Portfolio Table 80. Broncus Recent Development Table 81. LungCare Company Information Table 82. LungCare Business Overview Table 83. LungCare Lung Tumor Ablation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. LungCare Lung Tumor Ablation Product Portfolio Table 85. LungCare Recent Development Table 86. Medtronic Company Information Table 87. Medtronic Business Overview Table 88. Medtronic Lung Tumor Ablation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Medtronic Lung Tumor Ablation Product Portfolio Table 90. Medtronic Recent Development Table 91. TIPC Company Information Table 92. TIPC Business Overview Table 93. TIPC Lung Tumor Ablation Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. TIPC Lung Tumor Ablation Product Portfolio Table 95. TIPC Recent Development Table 96. North America Lung Tumor Ablation Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Lung Tumor Ablation Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Lung Tumor Ablation Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Lung Tumor Ablation Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Lung Tumor Ablation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Lung Tumor Ablation Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Lung Tumor Ablation Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Lung Tumor Ablation Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Lung Tumor Ablation Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Lung Tumor Ablation Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Lung Tumor Ablation Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Lung Tumor Ablation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Lung Tumor Ablation Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Lung Tumor Ablation Revenue by Country (US$ Million) & (2027-2032) Table 110. China Lung Tumor Ablation Revenue by Type (2021-2026) & (US$ Million) Table 111. China Lung Tumor Ablation Revenue by Type (2027-2032) & (US$ Million) Table 112. China Lung Tumor Ablation Revenue by Application (2021-2026) & (US$ Million) Table 113. China Lung Tumor Ablation Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Lung Tumor Ablation Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Lung Tumor Ablation Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Lung Tumor Ablation Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Lung Tumor Ablation Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Lung Tumor Ablation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Lung Tumor Ablation Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Lung Tumor Ablation Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Lung Tumor Ablation Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Lung Tumor Ablation Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Lung Tumor Ablation Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Lung Tumor Ablation Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Lung Tumor Ablation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Lung Tumor Ablation Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Lung Tumor Ablation Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Lung Tumor Ablation Image Figure 2. Global Lung Tumor Ablation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung Tumor Ablation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microwave Ablation (MWA) Image Figure 5. Radiofrequency Ablation (RFA) Image Figure 6. Cold Ablation Image Figure 7. Others Image Figure 8. Global Lung Tumor Ablation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Lung Tumor Ablation Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Ambulatory Surgical Centers Image Figure 12. Global Lung Tumor Ablation Market Size (US$ Million) & (2021-2032) Figure 13. Global Lung Tumor Ablation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Lung Tumor Ablation Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Lung Tumor Ablation Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Lung Tumor Ablation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Lung Tumor Ablation Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Lung Tumor Ablation Revenue Market Share by Type (2021-2032) Figure 20. Global Lung Tumor Ablation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Lung Tumor Ablation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Lung Tumor Ablation Revenue Market Share by Application (2021-2032) Figure 23. North America Lung Tumor Ablation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Lung Tumor Ablation Revenue Share by Type (2021-2032) Figure 25. North America Lung Tumor Ablation Revenue Share by Application (2021-2032) Figure 26. North America Lung Tumor Ablation Revenue Share by Country (2021-2032) Figure 27. United States Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Lung Tumor Ablation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Lung Tumor Ablation Revenue Share by Type (2021-2032) Figure 32. Europe Lung Tumor Ablation Revenue Share by Application (2021-2032) Figure 33. Europe Lung Tumor Ablation Revenue Share by Country (2021-2032) Figure 34. Germany Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Lung Tumor Ablation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Lung Tumor Ablation Revenue Share by Type (2021-2032) Figure 44. China Lung Tumor Ablation Revenue Share by Application (2021-2032) Figure 45. Asia Lung Tumor Ablation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Lung Tumor Ablation Revenue Share by Type (2021-2032) Figure 47. Asia Lung Tumor Ablation Revenue Share by Application (2021-2032) Figure 48. Asia Lung Tumor Ablation Revenue Share by Region (2021-2032) Figure 49. Japan Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Lung Tumor Ablation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Lung Tumor Ablation Revenue Share by Type (2021-2032) Figure 57. SAMEA Lung Tumor Ablation Revenue Share by Application (2021-2032) Figure 58. SAMEA Lung Tumor Ablation Revenue Share by Country (2021-2032) Figure 59. Brazil Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Lung Tumor Ablation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Microwave Ablation (MWA)
  • Radiofrequency Ablation (RFA)
  • Cold Ablation
  • Others
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Angiodynamics
  • Auris Health
  • Intuitive Surgica
  • Nanjing MICRO-TECH
  • Smith and Nephew
  • VISON Medical
  • Olympus
  • Boston Scientific
  • Broncus
  • LungCare
  • Medtronic
  • TIPC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lung Tumor Ablation Market by Type
  3. 1.2.1 Global Lung Tumor Ablation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microwave Ablation (MWA)
  5. 1.2.3 Radiofrequency Ablation (RFA)
  6. 1.2.4 Cold Ablation
  7. 1.2.5 Others
  8. 1.3 Lung Tumor Ablation Market by Application
  9. 1.3.1 Global Lung Tumor Ablation Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Ambulatory Surgical Centers
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Lung Tumor Ablation Market Dynamics
  1. 2.1 Lung Tumor Ablation Industry Trends
  2. 2.2 Lung Tumor Ablation Industry Drivers
  3. 2.3 Lung Tumor Ablation Industry Opportunities and Challenges
  4. 2.4 Lung Tumor Ablation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lung Tumor Ablation Market Perspective (2021-2032)
  2. 3.2 Global Lung Tumor Ablation Growth Trends by Region
  3. 3.2.1 Global Lung Tumor Ablation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lung Tumor Ablation Market Size by Region (2021-2026)
  5. 3.2.3 Global Lung Tumor Ablation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lung Tumor Ablation Revenue by Players
  2. 4.1.1 Global Lung Tumor Ablation Revenue by Players (2021-2026)
  3. 4.1.2 Global Lung Tumor Ablation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lung Tumor Ablation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lung Tumor Ablation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lung Tumor Ablation Key Players Headquarters & Area Served
  7. 4.4 Global Lung Tumor Ablation Players, Product Type & Application
  8. 4.5 Global Lung Tumor Ablation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lung Tumor Ablation Market CR5 and HHI
  11. 4.6.3 2025 Lung Tumor Ablation Tier 1, Tier 2, and Tier 3
5 Lung Tumor Ablation Market Size by Type
  1. 5.1 Global Lung Tumor Ablation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lung Tumor Ablation Revenue by Type (2021-2032)
  3. 5.3 Global Lung Tumor Ablation Revenue Market Share by Type (2021-2032)
6 Lung Tumor Ablation Market Size by Application
  1. 6.1 Global Lung Tumor Ablation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lung Tumor Ablation Revenue by Application (2021-2032)
  3. 6.3 Global Lung Tumor Ablation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Angiodynamics
  2. 7.1.1 Angiodynamics Company Information
  3. 7.1.2 Angiodynamics Business Overview
  4. 7.1.3 Angiodynamics Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Angiodynamics Lung Tumor Ablation Product Portfolio
  6. 7.1.5 Angiodynamics Recent Developments
  7. 7.2 Auris Health
  8. 7.2.1 Auris Health Company Information
  9. 7.2.2 Auris Health Business Overview
  10. 7.2.3 Auris Health Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Auris Health Lung Tumor Ablation Product Portfolio
  12. 7.2.5 Auris Health Recent Developments
  13. 7.3 Intuitive Surgica
  14. 7.3.1 Intuitive Surgica Company Information
  15. 7.3.2 Intuitive Surgica Business Overview
  16. 7.3.3 Intuitive Surgica Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Intuitive Surgica Lung Tumor Ablation Product Portfolio
  18. 7.3.5 Intuitive Surgica Recent Developments
  19. 7.4 Nanjing MICRO-TECH
  20. 7.4.1 Nanjing MICRO-TECH Company Information
  21. 7.4.2 Nanjing MICRO-TECH Business Overview
  22. 7.4.3 Nanjing MICRO-TECH Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nanjing MICRO-TECH Lung Tumor Ablation Product Portfolio
  24. 7.4.5 Nanjing MICRO-TECH Recent Developments
  25. 7.5 Smith and Nephew
  26. 7.5.1 Smith and Nephew Company Information
  27. 7.5.2 Smith and Nephew Business Overview
  28. 7.5.3 Smith and Nephew Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Smith and Nephew Lung Tumor Ablation Product Portfolio
  30. 7.5.5 Smith and Nephew Recent Developments
  31. 7.6 VISON Medical
  32. 7.6.1 VISON Medical Company Information
  33. 7.6.2 VISON Medical Business Overview
  34. 7.6.3 VISON Medical Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 VISON Medical Lung Tumor Ablation Product Portfolio
  36. 7.6.5 VISON Medical Recent Developments
  37. 7.7 Olympus
  38. 7.7.1 Olympus Company Information
  39. 7.7.2 Olympus Business Overview
  40. 7.7.3 Olympus Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Olympus Lung Tumor Ablation Product Portfolio
  42. 7.7.5 Olympus Recent Developments
  43. 7.8 Boston Scientific
  44. 7.8.1 Boston Scientific Company Information
  45. 7.8.2 Boston Scientific Business Overview
  46. 7.8.3 Boston Scientific Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boston Scientific Lung Tumor Ablation Product Portfolio
  48. 7.8.5 Boston Scientific Recent Developments
  49. 7.9 Broncus
  50. 7.9.1 Broncus Company Information
  51. 7.9.2 Broncus Business Overview
  52. 7.9.3 Broncus Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Broncus Lung Tumor Ablation Product Portfolio
  54. 7.9.5 Broncus Recent Developments
  55. 7.10 LungCare
  56. 7.10.1 LungCare Company Information
  57. 7.10.2 LungCare Business Overview
  58. 7.10.3 LungCare Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 LungCare Lung Tumor Ablation Product Portfolio
  60. 7.10.5 LungCare Recent Developments
  61. 7.11 Medtronic
  62. 7.11.1 Medtronic Company Information
  63. 7.11.2 Medtronic Business Overview
  64. 7.11.3 Medtronic Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Medtronic Lung Tumor Ablation Product Portfolio
  66. 7.11.5 Medtronic Recent Developments
  67. 7.12 TIPC
  68. 7.12.1 TIPC Company Information
  69. 7.12.2 TIPC Business Overview
  70. 7.12.3 TIPC Lung Tumor Ablation Revenue and Gross Margin (2021-2026)
  71. 7.12.4 TIPC Lung Tumor Ablation Product Portfolio
  72. 7.12.5 TIPC Recent Developments
8 North America
  1. 8.1 North America Lung Tumor Ablation Revenue (2021-2032)
  2. 8.2 North America Lung Tumor Ablation Revenue by Type (2021-2032)
  3. 8.2.1 North America Lung Tumor Ablation Revenue by Type (2021-2026)
  4. 8.2.2 North America Lung Tumor Ablation Revenue by Type (2027-2032)
  5. 8.3 North America Lung Tumor Ablation Revenue Share by Type (2021-2032)
  6. 8.4 North America Lung Tumor Ablation Revenue by Application (2021-2032)
  7. 8.4.1 North America Lung Tumor Ablation Revenue by Application (2021-2026)
  8. 8.4.2 North America Lung Tumor Ablation Revenue by Application (2027-2032)
  9. 8.5 North America Lung Tumor Ablation Revenue Share by Application (2021-2032)
  10. 8.6 North America Lung Tumor Ablation Revenue by Country
  11. 8.6.1 North America Lung Tumor Ablation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lung Tumor Ablation Revenue by Country (2021-2026)
  13. 8.6.3 North America Lung Tumor Ablation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lung Tumor Ablation Revenue (2021-2032)
  2. 9.2 Europe Lung Tumor Ablation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lung Tumor Ablation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lung Tumor Ablation Revenue by Type (2027-2032)
  5. 9.3 Europe Lung Tumor Ablation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lung Tumor Ablation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lung Tumor Ablation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lung Tumor Ablation Revenue by Application (2027-2032)
  9. 9.5 Europe Lung Tumor Ablation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lung Tumor Ablation Revenue by Country
  11. 9.6.1 Europe Lung Tumor Ablation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lung Tumor Ablation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lung Tumor Ablation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lung Tumor Ablation Revenue (2021-2032)
  2. 10.2 China Lung Tumor Ablation Revenue by Type (2021-2032)
  3. 10.2.1 China Lung Tumor Ablation Revenue by Type (2021-2026)
  4. 10.2.2 China Lung Tumor Ablation Revenue by Type (2027-2032)
  5. 10.3 China Lung Tumor Ablation Revenue Share by Type (2021-2032)
  6. 10.4 China Lung Tumor Ablation Revenue by Application (2021-2032)
  7. 10.4.1 China Lung Tumor Ablation Revenue by Application (2021-2026)
  8. 10.4.2 China Lung Tumor Ablation Revenue by Application (2027-2032)
  9. 10.5 China Lung Tumor Ablation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lung Tumor Ablation Revenue (2021-2032)
  2. 11.2 Asia Lung Tumor Ablation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lung Tumor Ablation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lung Tumor Ablation Revenue by Type (2027-2032)
  5. 11.3 Asia Lung Tumor Ablation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lung Tumor Ablation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lung Tumor Ablation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lung Tumor Ablation Revenue by Application (2027-2032)
  9. 11.5 Asia Lung Tumor Ablation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lung Tumor Ablation Revenue by Country
  11. 11.6.1 Asia Lung Tumor Ablation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lung Tumor Ablation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lung Tumor Ablation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lung Tumor Ablation Revenue (2021-2032)
  2. 12.2 SAMEA Lung Tumor Ablation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lung Tumor Ablation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lung Tumor Ablation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lung Tumor Ablation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lung Tumor Ablation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lung Tumor Ablation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lung Tumor Ablation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lung Tumor Ablation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lung Tumor Ablation Revenue by Country
  11. 12.6.1 SAMEA Lung Tumor Ablation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lung Tumor Ablation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lung Tumor Ablation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst